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Is Rome III Criteria for Irritable Bowel Syndrome 
M o r e  U s e f u l  T h a n  R o m e  I I  C r i t e r i a  i n  K o r e a ?
TO THE EDITOR: Irritable bowel syndrome (IBS) is one of the 
most common disorders in primary care and gastroenterology 
practices.
1 The prevalence of IBS varies widely from 3.3% to 
12.1% with diagnostic criteria even in the same population.
2 We 
still do not know the true prevalence of IBS. Accurately de-
termining the epidemiology of IBS is important to provide basis 
for assessing the burden of disease in socio-cultural, healthcare 
and economic terms. With great interest, I read the report by 
Park et al
3 regarding the differences in prevalence and socio-
demographic characteristics of irritable bowel syndrome accord-
ing to Rome II and Rome III. In table 3, the authors presented a 
good agreement in the prevalence of IBS based on the diagnostic 
criteria. However a good agreement between Rome II and Rome 
III criteria in diagnosing IBS is inconsistent with the results of 
study by Sperber et al.
4 A 3 to 4-fold of increase was observed in 
IBS prevalence with Rome III criteria (11.4% vs 2.9%) in 
Sperber's study.
4 Another interesting finding of this study was a 
higher prevalence of IBS by Rome II criteria compared with that 
of Sperber's study (8.0% vs 2.9%). A possible explanation for the 
difference in the prevalence of IBS between 2 studies may be the 
low response rate in Park’s study compared with that of Sperber's 
study (26.2% vs 54.0%). 
In table 5, the authors showed the sociodemographic charac-
teristics in group A, B and C. Group A was comprised of 16 sub-
jects who met Rome II criteria but not Rome III and Group C 
was comprised of 26 subjects who met Rome III criteria but not 
Rome II. Sixty-five subjects in Group B met both Rome II and 
III criteria. Although the socioeconomic characteristics of the 3 
groups were provided, there was no information regarding the 
psychological aspects. According to Sperber’s study,
4 individuals 
with Rome II criteria had more doctor visits, perception of stress 
and a negative global feeling. These findings suggest that Rome 
III criteria may better reflect the average IBS patient we see in 
our clinics. Clinical usefulness of Rome III criteria in IBS is still 
needed to be investigated. 
Despite several limitations of the present study, it provides us 
with the important clues in  understanding the epidemiological 
characteristics of Korean IBS patients based on Rome II and III 
criteria. Further large studies are needed to apply Rome III cri-
teria widely to clinical practices and researches in Korea.
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